Abstract
410P Patients treated with pertuzumab followed by T-DM1 for breast cancer in France from 2014 to 2021: A survival analysis of 10,408 patients from the French National Hospital discharge summary database (PMSI)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have